Back to results
US 11,110,091 B2Granted
Modulators of toll-like receptors
AssigneeGilead Sciences, Inc.
InventorsManoj C. Desai, Randall L. Halcomb, Paul Hrvatin, Hon Chung Hui, Ryan McFadden, Paul A. Roethle, Hong Yang
Life of this patent
Estimating the term…
Abstract
Provided are modulators of TLRs of Formula II: pharmaceutically acceptable salts thereof, compositions containing such compounds, and therapeutic methods that include the administration of such compounds.
Claims3
A compound of Formula II:
- or a pharmaceutically acceptable salt thereof, wherein:
- Y—Z is —CR4R5—CR4R5;
- L1 is —NH— or —O—;
- R1 is C1-C6 alkyl C3-C12 saturated carbocyclyl, C4-C20 saturated carbocyclylalkyl, or C6-C20 arylalkyl;
- X1 is —CH2;
- D is phenyl substituted with -L2-NR6R7;
- each L2 is independently C1-C6 alkylene;
- each R3 is independently halogen, cyano, or C1-C6 haloalkyl;
- n is 0 or 1;
- R4 and R5 are each H;
- R6 and R7 are each independently H, C1-C6 alkyl, or C4-C20 saturated carbocyclylalkyl, —C(O)R8, —S(O)R8, —S(O)2R8, or —C(O)OR8;
- or
- R6 and R7, taken together with the nitrogen to which they are both attached, form a 4-6 membered saturated heterocycle comprising 0 to 2 heteroatoms selected from N, O, or S;
- and
- R8 is H or C1-C6 alkyl.
12 more elements
A compound of formula:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.